Stock ATRC ATRICURE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AtriCure, Inc.

Equities

ATRC

US04963C2098

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
20.89 USD -5.99% Intraday chart for AtriCure, Inc. -9.84% -41.47%
05-02 Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating MT
05-01 Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, vs. Street Est of $106.9M MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,286 2,506 3,194 2,064 1,692 1,011 - -
Enterprise Value (EV) 1 1,317 2,518 3,210 2,063 1,623 947.4 934.2 912.2
P/E ratio -34.6 x -48.8 x 63.8 x -43.5 x -54.1 x -26.9 x -33.5 x -42.4 x
Yield - - - - - - - -
Capitalization / Revenue 5.57 x 12.1 x 11.6 x 6.25 x 4.24 x 2.19 x 1.92 x 1.7 x
EV / Revenue 5.71 x 12.2 x 11.7 x 6.24 x 4.06 x 2.05 x 1.78 x 1.54 x
EV / EBITDA -196 x -402 x -366 x -943 x 83.5 x 35.5 x 25.1 x 18.7 x
EV / FCF -47 x -100 x -136 x -52.9 x -216 x -947 x 93.4 x 35.1 x
FCF Yield -2.13% -1% -0.73% -1.89% -0.46% -0.11% 1.07% 2.85%
Price to Book 4.94 x 5.69 x 6.61 x 4.52 x 3.55 x 2.09 x 2.05 x 1.97 x
Nbr of stocks (in thousands) 39,550 45,023 45,932 46,508 47,395 48,382 - -
Reference price 2 32.51 55.67 69.53 44.38 35.69 20.89 20.89 20.89
Announcement Date 20-02-18 21-02-23 22-02-15 23-02-21 24-02-15 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 230.8 206.5 274.3 330.4 399.2 461.9 525.4 594.2
EBITDA 1 -6.717 -6.262 -8.776 -2.188 19.45 26.7 37.17 48.87
EBIT 1 -33.12 -44.23 -47.3 -42.67 -26.68 -30.91 -24.51 -19.25
Operating Margin -14.35% -21.42% -17.24% -12.92% -6.68% -6.69% -4.66% -3.24%
Earnings before Tax (EBT) 1 -35 -48.04 50.39 -46.2 -29.85 -36.8 -29.07 -23.53
Net income 1 -35.19 -48.16 50.2 -46.47 -34.85 -36.72 -29.63 -23.39
Net margin -15.25% -23.32% 18.3% -14.06% -8.73% -7.95% -5.64% -3.94%
EPS 2 -0.9400 -1.140 1.090 -1.020 -0.6600 -0.7776 -0.6238 -0.4928
Free Cash Flow 1 -27.99 -25.13 -23.53 -39.02 -7.514 -1 10 26
FCF margin -12.13% -12.17% -8.58% -11.81% -1.88% -0.22% 1.9% 4.38%
FCF Conversion (EBITDA) - - - - - - 26.91% 53.2%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 20-02-18 21-02-23 22-02-15 23-02-21 24-02-15 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 70.46 73.22 74.58 84.53 83.25 88.03 93.49 100.9 98.29 106.5 108.9 116.2 113.8 123.1 123.8
EBITDA 1 0.691 -2.13 -4.234 -3.199 -0.735 5.98 1.921 8.019 4.683 4.823 2.8 7.406 7.442 8.898 5.287
EBIT 1 98.67 -12.5 -14.15 -13.66 -10.72 -4.136 -5.782 -4.144 -8.089 -8.668 -10.92 -6.702 -7.008 -6.152 -9.456
Operating Margin 140.04% -17.08% -18.97% -16.16% -12.88% -4.7% -6.18% -4.11% -8.23% -8.14% -10.03% -5.77% -6.16% -5% -7.64%
Earnings before Tax (EBT) 1 97.15 -13.69 -15.13 -14.8 -12.23 -4.049 -6.398 -5.025 -9.008 -9.416 -13.09 -8.317 -8.283 -6.85 -11.71
Net income 1 97.11 -13.74 -15.18 -14.84 -12.27 -4.17 -6.476 -5.118 -9.055 -9.789 -13.27 -8.149 -8.316 -7.031 -11.89
Net margin 137.82% -18.77% -20.36% -17.56% -14.74% -4.74% -6.93% -5.07% -9.21% -9.19% -12.19% -7.01% -7.31% -5.71% -9.61%
EPS 2 2.110 -0.3000 -0.3300 -0.3200 -0.2700 -0.0900 -0.1400 -0.1100 -0.2000 -0.2100 -0.2800 -0.1676 -0.1764 -0.1538 -0.2478
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 21-11-03 22-02-15 22-05-03 22-08-02 22-11-01 23-02-21 23-05-02 23-07-25 23-11-01 24-02-15 24-05-01 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 31.2 11.5 16.1 - - - - -
Net Cash position 1 - - - 1.27 68.6 63.3 76.5 98.5
Leverage (Debt/EBITDA) -4.638 x -1.835 x -1.833 x - - - - -
Free Cash Flow 1 -28 -25.1 -23.5 -39 -7.51 -1 10 26
ROE (net income / shareholders' equity) -16.1% -12.9% -11.7% -9.88% -7.55% -7.77% -6.56% -4.92%
ROA (Net income/ Total Assets) -7.7% -6.68% -7.87% -7.74% -5.81% -5.96% -4.91% -3.23%
Assets 1 457.3 720.7 -638.2 600.4 599.7 616.2 603.7 724.1
Book Value Per Share 2 6.580 9.790 10.50 9.810 10.10 10.00 10.20 10.60
Cash Flow per Share - - - - - - - -
Capex 1 12.2 5.26 9.75 16.9 12 14 15.9 17.9
Capex / Sales 5.28% 2.55% 3.56% 5.11% 3.01% 3.02% 3.03% 3.01%
Announcement Date 20-02-18 21-02-23 22-02-15 23-02-21 24-02-15 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for AtriCure, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
20.89 USD
Average target price
47.33 USD
Spread / Average Target
+126.58%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ATRICURE, INC. Stock AtriCure, Inc.
-41.47% 1.01B
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.84% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 67.8B
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 51.05B
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.67B
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.78B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.78B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.59B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.86B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ATRC Stock
  4. Financials AtriCure, Inc.